Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 1;92(3):236-245.
doi: 10.1016/j.biopsych.2021.11.026. Epub 2021 Dec 22.

Genetic Association of Attention-Deficit/Hyperactivity Disorder and Major Depression With Suicidal Ideation and Attempts in Children: The Adolescent Brain Cognitive Development Study

Affiliations

Genetic Association of Attention-Deficit/Hyperactivity Disorder and Major Depression With Suicidal Ideation and Attempts in Children: The Adolescent Brain Cognitive Development Study

Phil H Lee et al. Biol Psychiatry. .

Abstract

Background: Suicide is among the leading causes of death in children and adolescents. There are well-known risk factors of suicide, including childhood abuse, family conflicts, social adversity, and psychopathology. While suicide risk is also known to be heritable, few studies have investigated genetic risk in younger individuals.

Methods: Using polygenic risk score analysis, we examined whether genetic susceptibility to major psychiatric disorders is associated with suicidal behaviors among 11,878 children enrolled in the ABCD (Adolescent Brain Cognitive Development) Study. Suicidal ideation and suicide attempt data were assessed using the youth report of the Kiddie Schedule for Affective Disorders and Schizophrenia for DSM-5. After performing robust quality control of genotype data, unrelated individuals of European descent were included in analyses (n = 4344).

Results: Among 8 psychiatric disorders we examined, depression polygenic risk scores were associated with lifetime suicide attempts both in the baseline (odds ratio = 1.55, 95% CI = 1.10-2.18, p = 1.27 × 10-2) and in the follow-up year (odds ratio = 1.38, 95% CI = 1.08-1.77, p = 1.05 × 10-2), after adjusting for children's age, sex, socioeconomic backgrounds, family history of suicide, and psychopathology. In contrast, attention-deficit/hyperactivity disorder polygenic risk scores were associated with lifetime suicidal ideation (odds ratio = 1.15, 95% CI = 1.05-1.26, p = 3.71 × 10-3), suggesting a distinct contribution of the genetic risk underlying attention-deficit/hyperactivity disorder and depression on suicidal behaviors of children.

Conclusions: The largest genetic sample of suicide risk data in U.S. children suggests a significant genetic basis of suicide risk related to attention-deficit/hyperactivity disorder and depression. Further research is warranted to examine whether incorporation of genomic risk may facilitate more targeted screening and intervention efforts.

Keywords: ADHD; Adolescents; Children; Depression; Polygenic risk score; Suicide.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this article. RHP has received fees for consulting or service on scientific advisory boards for Genomind, Psy Therapeutics, Outermost Therapeutics, RID Ventures, and Takeda. He has received patent royalties from Massachusetts General Hospital. He holds equity in Psy Therapeutics and Outermost Therapeutics. In the past 3 years, RCK was a consultant for Datastat, Inc., Holmusk, RallyPoint Networks, Inc., and Sage Pharmaceuticals. He has stock options in Mirah, PYM, and Roga Sciences. MF has lifetime research support from Abbott Laboratories, Acadia Pharmaceuticals, Alkermes, Inc., American Cyanamid, Aspect Medical Systems, AstraZeneca, Avanir Pharmaceuticals, AXSOME Therapeutics, BioClinica, Inc, Biohaven, BioResearch, BrainCells Inc., Bristol-Myers Squibb, CeNeRx BioPharma, Cephalon, Cerecor, Clarus Funds, Clexio Biosciences, Clintara, LLC, Covance, Covidien, Eli Lilly and Company, EnVivo Pharmaceuticals, Inc., Euthymics Bioscience, Inc., Forest Pharmaceuticals, Inc., FORUM Pharmaceuticals, Ganeden Biotech, Inc., Gentelon, LLC, GlaxoSmithKline, Harvard Clinical Research Institute, Hoffman-LaRoche, Icon Clinical Research, Indivior, i3 Innovus/Ingenix, Janssen R&D, LLC, Jed Foundation, Johnson & Johnson Pharmaceutical Research & Development, Lichtwer Pharma GmbH, Lorex Pharmaceuticals, Lundbeck Inc., Marinus Pharmaceuticals, MedAvante, Methylation Sciences Inc, Brain & Behavior Research Foundation (formerly National Alliance for Research on Schizophrenia & Depression), National Center for Complementary and Alternative Medicine, National Coordinating Center for Integrated Medicine, National Institute on Drug Abuse, National Institutes of Health, National Institute of Mental Health, Neuralstem, Inc., NeuroRx, Novartis AG, Organon Pharmaceuticals, Otsuka Pharmaceutical Development, Inc., PamLab, LLC., Pfizer Inc., Pharmacia-Upjohn, Pharmaceutical Research Associates., Inc., Pharmavite LLC, PharmoRx Therapeutics, Photothera, Premiere Research International, Protagenic Therapeutics, Inc., Reckitt Benckiser, Relmada Therapeutics Inc., Roche Pharmaceuticals, RCT Logic, LLC (formerly Clinical Trials Solutions, LLC), Sanofi-Aventis US LLC, Shenox Pharmaceuticals, LLC, Shire, Solvay Pharmaceuticals, Inc., Stanley Medical Research Institute, Synthélabo, Taisho Pharmaceuticals, Takeda Pharmaceuticals, Tal Medical, VistaGen, and Wyeth-Ayerst Laboratories. He also has equity holdings at Compellis and Psy Therapeutics. All other authors report no biomedical financial interests or potential conflicts of interest.

Figures

Figure 1.
Figure 1.
Study outline of the polygenic risk score (PRS) analyses. Our study used ABCD (Adolescent Brain Cognitive Development) Study data release 3.0, which included genetics and phenotypic data collected in the baseline and the first follow-up year for 11,877 participants. Suicidal data were collected using the youth version of the computerized Kiddie Schedule for Affective Disorders and Schizophrenia for DSM-5. Using the individual item data, we generated 3 lifetime suicide-related measures, encompassing nonsuicidal self-injury (NSSI), suicidal ideation (SI), and suicide attempt (SA). Well-known risk factors of suicide were included in the analysis using the ABCD Study survey data. For PRS data generation, 8 psychiatric disorder genome-wide association studies (GWASs) of the largest available sample size were applied to 4344 ABCD participants of European ancestry. SNP, single nucleotide polymorphism.
Figure 2.
Figure 2.
Logistic regression analysis results for testing the association between 8 psychiatric disorder polygenic risk scores and lifetime suicide risk outcome measures. Odds ratio (OR) represents the exponential of the logistic regression estimates. Error bars represent 95% confidence intervals of ORs. ADHD, attention-deficit/hyperactivity disorder; PTSD, posttraumatic stress disorder; NSSI, nonsuicidal self-injury; SA, suicide attempt; SI, suicidal ideation.
Figure 3.
Figure 3.
Association analysis results of major depression (MD) and attention-deficit/hyperactivity disorder (ADHD) polygenic risk scores (PRSs) with known risk factors of suicide. (A) Partial correlations were measured between PRSs and 11 Child Behavior Checklist items, conditioning on age, sex, and 10 genetic principal components to control for potential population substratification within Europeans. The y-axis represents the t-statistics of partial correlation measures. (B) The t-test results for comparing ADHD and MD PRSs between 2 groups of participants stratified by various risk factors. Participants were divided into two groups based on family history of suicide, parent college education, and poverty. Poverty was set at yes if the household income of the participants was less than $20,000 annually. The top panels display MD PRS scores on the y-axis, while the bottom panels show ADHD PRS scores. aggressive = aggressive behavior; anxdep = anxious/depressed; attention = attention problems; external = externalizing problems; internal = internalizing problems; rulebreak = rule-breaking behavior; social = social problems; somatic = somatic complaints; thought = thought problems; totprob = total problem score; withdep = withdrawn/depressed.

Comment in

Similar articles

Cited by

References

    1. Xu J, Murphy SL, Kockanek KD, Arias E (2020): Mortality in the United States, 2018. NCHS Data Brief, no. 355. Hyattesville, MD: National Center for Health Statistics. - PubMed
    1. World Health Organization (2014): Global Health Estimates 2013: Deaths by Cause, Age and Sex, Estimates for 2000–2012. Geneva: World Health Organization.
    1. World Health Organization: WHO Suicide data. Available at: https://www.who.int/data/gho/data/themes/mental-health/suicide-rates. Accessed February 7, 2022.
    1. Appleby L, Kapur N, Shaw J, Rodway C, Turnbull P, Ibrahim S, et al. (2017): Suicide by children and young people. National Confidential Inquiry into Suicide and Homicide by People with Mental Illness (NCISH). Manchester: University of Manchester.
    1. Hawton K, Bale L, Brand F, Townsend E, Ness J, Waters K, et al. (2020): Mortality in children and adolescents following presentation to hospital after non-fatal self-harm in the Multicentre Study of Self-harm: A prospective observational cohort study. Lancet Child Adolesc Health 4:111–120. - PubMed

Publication types

MeSH terms